{"id":6843,"date":"2025-08-19T11:36:06","date_gmt":"2025-08-19T15:36:06","guid":{"rendered":"https:\/\/cqdm.org\/?p=6843"},"modified":"2025-08-19T11:41:58","modified_gmt":"2025-08-19T15:41:58","slug":"congratulations-to-glycovax-pharma-for-two-major-advances-in-the-field-of-vaccines","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/congratulations-to-glycovax-pharma-for-two-major-advances-in-the-field-of-vaccines\/","title":{"rendered":"Congratulations to Glycovax Pharma for two major advances in the field of vaccines"},"content":{"rendered":"\n<p>The CQDM is pleased to highlight the recent achievements of one of its members, <strong>Glycovax Pharma<\/strong>, a Montreal-based biopharmaceutical company specializing in glyco-immunology and the development of semi-synthetic vaccines.<\/p>\n\n\n\n<p>On one hand, Glycovax is launching large-scale production of the <strong>SLA vaccine adjuvant<\/strong>, an innovative compound developed by the <strong>National Research Council of Canada (NRC)<\/strong>, which has demonstrated exceptional ability to enhance immune response and improve the effectiveness of both existing and next-generation vaccines.<br>\ud83d\udc49 Read the press release: <em><a href=\"https:\/\/glycovax.com\/glycovax-pharma-launches-a-highly-performant-sla-adjuvant-2\/\" target=\"_blank\" rel=\"noopener\">Glycovax Pharma launches a highly performant SLA Adjuvant &#8211; Glycovax Pharma<\/a><\/em><\/p>\n\n\n\n<p>On the other hand, the company has obtained an <strong>exclusive license from the NRC<\/strong> to develop a vaccine against <em>Pseudomonas aeruginosa<\/em>, an antibiotic-resistant hospital-acquired bacterium identified by the WHO as a priority target.<br>\ud83d\udc49 Read the press release: <em><a href=\"https:\/\/glycovax.com\/glycovax-pharma-granted-nrc-licence-to-develop-pseudomonas-aeruginosa-vaccine\/\" target=\"_blank\" rel=\"noopener\">Pseudomonas aeruginosa Vaccine | Glycovax Granted NRC Licence<\/a><\/em><\/p>\n\n\n\n<p>These breakthroughs confirm Glycovax\u2019s leading role in developing innovative vaccine solutions to address urgent global medical needs.<\/p>\n\n\n\n<p>Learn more about Glycovax Pharma: <a href=\"http:\/\/www.glycovax.com\" target=\"_blank\" rel=\"noopener\"><a href=\"https:\/\/glycovax.com\/\" target=\"_blank\" rel=\"noopener\">Glycovax \u2013 Advancing Next-Generation Conjugate Vaccines<\/a><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The CQDM is pleased to highlight the recent achievements of one of its members, Glycovax Pharma, a Montreal-based biopharmaceutical company specializing in glyco-immunology and the development of semi-synthetic vaccines. On one hand, Glycovax is launching large-scale production of the SLA vaccine adjuvant, an innovative compound developed by the National Research Council of Canada (NRC), which&hellip;<\/p>\n","protected":false},"author":5,"featured_media":6853,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-6843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-from-the-industry"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/6843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=6843"}],"version-history":[{"count":1,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/6843\/revisions"}],"predecessor-version":[{"id":6855,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/6843\/revisions\/6855"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/6853"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=6843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=6843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=6843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}